Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal

The dual antagonist effects of the mixed-action μ-opioid partial agonist/κ-opioid antagonist buprenorphine have not been previously compared in behavioral studies, and it is unknown whether they are comparably modified by chronic exposure. To address this question, the dose-related effects of levorp...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of pharmacology and experimental therapeutics Jg. 336; H. 2; S. 488
Hauptverfasser:	Paronis, Carol A, Bergman, Jack
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.02.2011
Schlagworte:	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer - antagonists & inhibitors Animals Buprenorphine - blood Buprenorphine - pharmacology Dose-Response Relationship, Drug Drug Tolerance Female Levorphanol - antagonists & inhibitors Macaca mulatta Male Naltrexone - pharmacology Narcotic Antagonists - pharmacology Substance Withdrawal Syndrome - etiology
ISSN:	1521-0103, 1521-0103
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!